On site at ESGCT Annual Congress 2026
Connecting with the international cell and gene therapy community and presenting our latest poster on EvoLVcell.
From October 27 to 30, we are attending the European Society of Gene and Cell Therapy (ESGCT) Annual Congress 2026 in Hamburg as a Silver Sponsor.
Held in collaboration with DGGZT e.V., the Congress brings together the international cell and gene therapy community for four days of scientific exchange, conversations and new connections.
Throughout the Congress, our team will be at Booth E-15, where attendees can connect with us, share their current challenges and discuss how our lentiviral vector expertise can support their specific needs for ex vivo and in vivo applications.
Our participation also includes a scientific contribution focused on EvoLVcell. Tomorrow from 1:30 to 3:30 PM, we will present Poster P0825, “EvoLVcell: A Producer Cell Line Platform for Scalable, Transfection-Free, and High-Quality Lentiviral Vector Manufacturing.” The poster presents our latest work on EvoLVcell, our producer cell line platform for scalable, transfection-free lentiviral vector manufacturing.
Our team in Hamburg includes Stefan Beyer, Jon Alberdi, Natalia Elizalde, Marie Fertin, Giovanna Zanella, Andrés Lamsfus-Calle, Miguel Alvarez and Víctor Polo.
If you are attending ESGCT, visit us at Booth E-15 to connect with the team and learn more about our lentiviral vector expertise. If you are not attending the Congress but would like to discuss your programme, contact us at info@vivebiotech.com.
